1. Home
  2. APLM vs MHUA Comparison

APLM vs MHUA Comparison

Compare APLM & MHUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLM
  • MHUA
  • Stock Information
  • Founded
  • APLM 2016
  • MHUA 1990
  • Country
  • APLM United States
  • MHUA China
  • Employees
  • APLM N/A
  • MHUA N/A
  • Industry
  • APLM Blank Checks
  • MHUA Medical Specialities
  • Sector
  • APLM Finance
  • MHUA Health Care
  • Exchange
  • APLM Nasdaq
  • MHUA Nasdaq
  • Market Cap
  • APLM 6.9M
  • MHUA 19.6M
  • IPO Year
  • APLM N/A
  • MHUA 2022
  • Fundamental
  • Price
  • APLM $6.14
  • MHUA $0.44
  • Analyst Decision
  • APLM
  • MHUA
  • Analyst Count
  • APLM 0
  • MHUA 0
  • Target Price
  • APLM N/A
  • MHUA N/A
  • AVG Volume (30 Days)
  • APLM 7.8K
  • MHUA 154.1K
  • Earning Date
  • APLM 08-13-2025
  • MHUA 04-25-2025
  • Dividend Yield
  • APLM N/A
  • MHUA N/A
  • EPS Growth
  • APLM N/A
  • MHUA N/A
  • EPS
  • APLM N/A
  • MHUA 0.40
  • Revenue
  • APLM $198,000.00
  • MHUA $96,909,642.00
  • Revenue This Year
  • APLM $415.15
  • MHUA N/A
  • Revenue Next Year
  • APLM N/A
  • MHUA N/A
  • P/E Ratio
  • APLM N/A
  • MHUA $1.09
  • Revenue Growth
  • APLM N/A
  • MHUA N/A
  • 52 Week Low
  • APLM $4.47
  • MHUA $0.25
  • 52 Week High
  • APLM $35.98
  • MHUA $1.47
  • Technical
  • Relative Strength Index (RSI)
  • APLM 47.85
  • MHUA 53.26
  • Support Level
  • APLM $6.21
  • MHUA $0.39
  • Resistance Level
  • APLM $6.80
  • MHUA $0.45
  • Average True Range (ATR)
  • APLM 0.52
  • MHUA 0.04
  • MACD
  • APLM 0.00
  • MHUA -0.00
  • Stochastic Oscillator
  • APLM 51.61
  • MHUA 86.39

About APLM Apollomics Inc.

Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.

About MHUA Meihua International Medical Technologies Co. Ltd.

Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.

Share on Social Networks: